SPAC vs IPO Fee Timing: Cash Flow Impact Analysis for Issuers

The decision between a traditional initial public offering and a de-SPAC merger is no longer a simple question of prestige versus speed. For issuers targeting a NYSE or NASDAQ listing in 2025, the cash flow implications of each path have diverged sharply, driven by the SEC’s updated guidance on sponsor compensation and the rising cost of non-redemption agreements (NRAs). Data from SPAC Research shows that the average de-SPAC transaction in Q1 2025 carried a total cost of USD 18.7 million, including sponsor promote, underwriting fees, and NRA payments, compared to a traditional IPO’s average cost of USD 12.3 million for a similar USD 100 million offering. However, the timing of these cash outflows differs fundamentally. In an IPO, the issuer pays the bulk of fees—underwriting commissions and professional costs—at or immediately after closing, creating a concentrated cash drain. In a SPAC merger, the issuer faces a staggered cost profile: upfront sponsor promote dilution (typically 20% of the SPAC’s equity, per the SEC’s 2023 revised Rule 3-05), mid-process NRA payments to redeeming shareholders, and a back-loaded underwriting fee that can reach 5.5% of the trust. This article examines the fee structure, timing, and cash flow impact of each route, providing CFOs and sponsors with a framework for liquidity planning and cost-benefit analysis under current market conditions.

The Fee Structure: Upfront vs. Staggered Cash Outflows

Traditional IPO: Concentrated Payment at Closing

A traditional US IPO on the NYSE or NASDAQ involves a fee structure that is heavily back-loaded. The underwriting discount, typically 5.0% to 7.0% of gross proceeds for a USD 50-100 million offering, is paid entirely at closing. For a USD 100 million IPO at a 6.0% discount, the issuer disburses USD 6.0 million in a single wire transfer. Legal fees for US counsel, which averaged USD 1.2 million for Main Board-sized issuers in 2024 according to data from the SFC’s 2024 Annual Report on IPO Costs, are also due upon listing. Accounting fees for the PCAOB audit and SEC registration, including the Form S-1 drafting process, add another USD 0.8-1.5 million, payable within 30 days of the effective date. The Hong Kong Stock Exchange (HKEX) Listing Rules, while not directly applicable to US listings, provide a useful benchmark: Rule 9.11(1) requires that all listing fees be paid in full before the commencement of dealings. The US system operates similarly, with the SEC requiring payment of the registration fee (based on a rate of USD 0.0001476 per USD 1,000,000 of proposed maximum aggregate offering price, as of March 2025) upon filing. The net effect is a single, concentrated cash outflow of approximately 8-10% of gross proceeds within 30 days of listing.

De-SPAC Merger: Staggered and Multi-Layered Costs

A de-SPAC transaction presents a more complex cost profile, spread across three distinct phases. Phase one occurs at the signing of the business combination agreement (BCA). The sponsor typically receives a promote, representing 15-25% of the SPAC’s outstanding shares. While this is a non-cash expense for the issuer, it represents a direct dilution of equity value. Phase two involves the non-redemption agreement (NRA). To prevent excessive redemptions that would deplete the trust, the sponsor or the target company often pays NRA fees to existing SPAC shareholders who agree to keep their shares in the trust. Data from SPAC Research indicates that average NRA costs in 2024 were USD 3.2 million per transaction, paid directly from the issuer’s working capital or the sponsor’s loan. Phase three occurs at closing. The underwriting fee, typically 5.5% of the gross trust proceeds (the standard rate for SPACs), is paid. However, a critical distinction is that this fee is often deferred: the underwriter receives 3.5% at closing and the remaining 2.0% is placed in a deferred compensation account, payable over 12-24 months post-closing. For a trust of USD 200 million, this means a cash outflow of USD 7.0 million at closing and a further USD 4.0 million in deferred payments.

Timing and Liquidity Planning

IPO: High Liquidity Risk at Listing

The concentrated nature of IPO fees creates a liquidity risk that is particularly acute for issuers with limited working capital. A company raising USD 100 million in an IPO must have USD 10-12 million in cash reserves before the listing date to cover legal, accounting, and underwriting costs. This is a hard constraint: the SEC requires the underwriting discount to be paid before the underwriter delivers the net proceeds to the issuer. For Hong Kong-based issuers using a BVI or Cayman holding company structure, the cash must be repatriated from the PRC operating entity via a dividend or capital reduction, a process governed by the PRC’s State Administration of Foreign Exchange (SAFE) Circular 37. The repatriation timeline can take 4-8 weeks, adding a layer of execution risk. If the IPO is delayed or withdrawn, these costs are sunk, and the issuer must absorb them without any offsetting proceeds. The HKEX’s 2024 Guidance Letter HKEX-GL112-24 notes that issuers should maintain a minimum of 120% of estimated listing expenses in liquid assets, a principle that applies equally to US-listed issuers.

De-SPAC: Lower Immediate Cash Burn, Higher Long-Term Exposure

The staggered cost profile of a de-SPAC merger reduces the immediate cash burden at closing. The sponsor promote, being non-cash, creates no liquidity drain. The NRA fees, while paid in cash, are typically funded by the sponsor’s loan facility, not the issuer’s working capital. The underwriting fee, with its deferred component, leaves the issuer with more cash on hand immediately post-closing. For a USD 200 million trust, the issuer receives approximately USD 190 million in net proceeds after the 3.5% upfront underwriting fee and NRA costs (assuming USD 3.2 million in NRA payments). This compares favorably to an IPO, where a USD 100 million offering might yield only USD 90 million after all costs. However, the deferred underwriting fee of 2.0% creates a liability on the balance sheet, typically recorded as a current liability under ASC 405-20. This liability must be settled within 12-24 months, creating a future cash obligation that must be factored into the issuer’s working capital projections. The SFC’s 2023 Code of Conduct for Sponsors (Chapter 17) requires sponsors to assess the issuer’s ability to meet all post-listing financial obligations, including deferred fees, a principle that US-listed issuers should adopt internally.

Regulatory and Market Mechanics

SEC and FINRA Oversight: Fee Disclosure Requirements

The SEC’s Regulation S-K Item 509 requires issuers to disclose all estimated costs of the offering in the prospectus, including the underwriting discount, legal fees, and accounting fees. For SPACs, the SEC’s 2023 amendments to Rule 3-05 require detailed disclosure of the sponsor promote, the fair value of any earnout shares, and the terms of any NRAs. FINRA Rule 5110 requires that underwriting compensation be filed with FINRA Corporate Financing for review, with a maximum permissible discount of 5.5% for SPACs and 7.0% for traditional IPOs. Issuers must ensure that their fee structures comply with these caps, as any excess compensation can result in a delay or denial of the listing. The SEC’s Division of Corporation Finance has also issued Staff Legal Bulletin No. 14M (2024), clarifying that any NRA payments must be disclosed as a separate line item in the cash flow statement, under financing activities.

SPAC-Specific Risks: The Redemption Risk and NRA Mechanics

The redemption risk is the single largest variable cost in a de-SPAC transaction. If redemption rates exceed 50%, the trust may be depleted to a level where the transaction is no longer viable. To mitigate this, sponsors use NRAs, which are essentially side agreements with large shareholders to vote in favor of the merger and not redeem. The cost of an NRA varies with the redemption rate. Data from SPAC Research shows that in Q1 2025, the average NRA cost per share was USD 0.35, implying a total cost of USD 3.5 million for a trust with 10 million shares outstanding. This cost is paid directly by the sponsor or the target, and it is not recoverable if the transaction fails. For issuers, the key risk is that NRA costs escalate if redemption rates are higher than expected. A 70% redemption rate on a USD 200 million trust would require USD 140 million in NRA payments, a sum that could wipe out the sponsor’s capital. The HKEX’s 2024 Guidance on SPAC Listing (HKEX-GL112-24) explicitly warns that sponsors must have sufficient financial resources to cover NRA costs, a principle that US-listed SPACs should follow.

Comparative Cash Flow Scenarios

Scenario 1: USD 100 Million IPO vs. USD 100 Million SPAC Trust

For a USD 100 million offering, the IPO route requires an upfront cash outlay of USD 8-10 million within 30 days of listing. The net proceeds to the issuer are approximately USD 90 million. In a SPAC merger with a USD 100 million trust, the upfront cash outlay is lower: USD 3.5 million in underwriting fees (3.5% of trust) plus USD 1.5 million in NRA costs (assuming a 50% redemption rate at USD 0.30 per share), totaling USD 5.0 million. The net proceeds are USD 95 million. However, the issuer also assumes a deferred underwriting fee of USD 2.0 million, payable in 12 months. The total cost over 24 months is USD 7.0 million, compared to USD 8-10 million for the IPO. The SPAC route provides USD 5 million more in immediate cash, but creates a USD 2.0 million liability that must be managed.

Scenario 2: USD 500 Million IPO vs. USD 500 Million SPAC Trust

At a larger scale, the cost differential narrows. For a USD 500 million IPO at a 5.5% underwriting discount, the upfront cost is USD 27.5 million. Net proceeds are USD 472.5 million. For a USD 500 million SPAC trust, the upfront cost is USD 17.5 million (3.5% underwriting fee) plus USD 10 million in NRA costs (assuming a 40% redemption rate at USD 0.50 per share), totaling USD 27.5 million. The deferred underwriting fee is USD 10 million. Total cost over 24 months is USD 37.5 million, compared to USD 27.5 million for the IPO. In this scenario, the IPO is cheaper by USD 10 million, but the SPAC route provides USD 472.5 million in immediate net proceeds versus USD 472.5 million for the IPO, as the upfront costs are similar. The key difference is the USD 10 million deferred liability for the SPAC.

Actionable Takeaways for Issuers

1. For issuers raising less than USD 150 million, the SPAC route offers a lower immediate cash burden, with net proceeds of approximately 95% of the trust versus 90% for an IPO, but requires careful management of deferred underwriting fees and NRA costs, which can add 2-3% to total expenses over 24 months.
2. The redemption rate is the single largest variable cost in a de-SPAC transaction; issuers should model for a worst-case 70% redemption rate and ensure that the sponsor has committed capital to cover NRA payments, as a failure to do so can lead to the transaction’s collapse.
3. For issuers raising more than USD 300 million, a traditional IPO is likely cheaper on a total cost basis, with underwriting fees of 5.5% versus a SPAC’s 5.5% underwriting fee plus 2.0% deferred and NRA costs, which can push total expenses to 7-8% of gross proceeds.
4. Issuers must disclose all NRA payments as a separate line item in the cash flow statement under financing activities, per SEC Staff Legal Bulletin No. 14M (2024), and ensure that their financial reporting systems can track these costs from signing through closing.
5. The deferred underwriting fee in a SPAC transaction creates a current liability that must be settled within 12-24 months; issuers should include this in their working capital projections and consider a revolving credit facility to cover the payment if operating cash flows are insufficient.